Enhanced Recovery After Surgery in Orthopaedic Spine Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

October 9, 2024

Study Completion Date

October 9, 2024

Conditions
Lumbar Surgery
Interventions
DRUG

Intravenous Infusion group

The intravenous infusion group will receive two medications via the intravenous infusion route. These medications are Ofirmev ( acetaminophen ) 1,000mg and tranexamic acid 2,000 mg , an antifibrinolytic drug. In addition to these drugs, study subjects will receive Celecoxib 200mg by mouth and Gabapentin 600 mg by mouth prior to operation.

DRUG

All oral administration group

Subjects in the oral administration group will receive the following pre-emptive analgesic drugs, acetaminophen 1,000mg, Celecoxib 200mg and gabapentin 600mg via the oral route prior to operation. In addition they will receive the antifibrinolytic drug, tranexamic acid 2,000mg via an oral route as well prior to operation.

Trial Locations (1)

95817

University of California Davis Medical Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT04562610 - Enhanced Recovery After Surgery in Orthopaedic Spine Surgery | Biotech Hunter | Biotech Hunter